MedTrace Logo

Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic Prostatectomy

NCT03214055 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2017-08-25

No results posted yet for this study

Summary

We aim to evaluate the change in optic nerve sheath diameters as a surrogate of intracranial pressure before and after mannitol administration in patients who undergo robot assisted laparoscopic radical prostatectomy with pneumoperitoneum and Trendelenburg position.

Conditions

Interventions

DRUG

Mannitol

The mannitol has been administered routinely to prevent renal dysfunction in patients undergoing robot-assisted laparoscopic radical prostatectomy. Participants will receive the mannitol as part of routine medical care, and we will evaluate the change in optic nerve sheath diameters before and after mannitol administration.

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Young-Kug Kim, MD,PhD · Asan Medical Center

Eligibility

Min Age
20 Years
Max Age
79 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-12
Primary Completion
2017-08-14
Completion
2017-08-20

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03214055 on ClinicalTrials.gov